{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/54.1-2522.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/54.1-2522.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/54.1-2522.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/54.1-2522.html"}],"law_id":69685,"edition_id":1,"section_id":69685,"structure_id":13315,"section_number":"54.1-2522","catch_line":"(Effective July 1, 2026) Reporting exemptions","history":"2002, c. 481; 2018, c. 772; 2019, c. 686; 2025, c. 298.","full_text":"The dispensing of covered substances under the following circumstances shall be exempt from the reporting requirements set forth in \u00a7 54.1-2521:\n\n1\n\nDispensing of manufacturers’ samples of such covered substances or of covered substances dispensed pursuant to an indigent patient program offered by a pharmaceutical manufacturer.2\n\nDispensing of covered substances by a practitioner of the healing arts to his patient in a bona fide medical emergency or when pharmaceutical services are not available.3\n\nAdministering of covered substances.\n\t\t\tDispensing of covered substances to inpatients in hospitals or nursing facilities licensed by the Board of Health or facilities that are otherwise authorized by law to operate as hospitals or nursing homes in the Commonwealth.5\n\nDispensing of covered substances to inpatients in hospices licensed by the Board of Health.6\n\nDispensing of covered substances by veterinarians to animals within the usual course of their professional practice for a course of treatment to last seven days or less or if such covered substance is feline buprenorphine or canine butorphanol.7\n\nDispensing of covered substances as otherwise provided in the Department’s regulations.","order_by":null,"text":{"0":{"id":251914,"text":"The dispensing of covered substances under the following circumstances shall be exempt from the reporting requirements set forth in \u00a7 54.1-2521:","type":"section","prefixes":[""],"prefix":"","entire_prefix":"","prefix_anchor":"","level":1,"next_prefix":"1"},"1":{"id":251915,"text":"Dispensing of manufacturers’ samples of such covered substances or of covered substances dispensed pursuant to an indigent patient program offered by a pharmaceutical manufacturer.","type":"section","prefixes":["1"],"prefix":"1","entire_prefix":"1","prefix_anchor":"1","level":1,"prior_prefix":"","next_prefix":"2"},"2":{"id":251916,"text":"Dispensing of covered substances by a practitioner of the healing arts to his patient in a bona fide medical emergency or when pharmaceutical services are not available.","type":"section","prefixes":["2"],"prefix":"2","entire_prefix":"2","prefix_anchor":"2","level":1,"prior_prefix":"1","next_prefix":"3"},"3":{"id":251917,"text":"Administering of covered substances.\n\t\t\tDispensing of covered substances to inpatients in hospitals or nursing facilities licensed by the Board of Health or facilities that are otherwise authorized by law to operate as hospitals or nursing homes in the Commonwealth.","type":"section","prefixes":["3"],"prefix":"3","entire_prefix":"3","prefix_anchor":"3","level":1,"prior_prefix":"2","next_prefix":"5"},"4":{"id":251918,"text":"Dispensing of covered substances to inpatients in hospices licensed by the Board of Health.","type":"section","prefixes":["5"],"prefix":"5","entire_prefix":"5","prefix_anchor":"5","level":1,"prior_prefix":"3","next_prefix":"6"},"5":{"id":251919,"text":"Dispensing of covered substances by veterinarians to animals within the usual course of their professional practice for a course of treatment to last seven days or less or if such covered substance is feline buprenorphine or canine butorphanol.","type":"section","prefixes":["6"],"prefix":"6","entire_prefix":"6","prefix_anchor":"6","level":1,"prior_prefix":"5","next_prefix":"7"},"6":{"id":251920,"text":"Dispensing of covered substances as otherwise provided in the Department’s regulations.","type":"section","prefixes":["7"],"prefix":"7","entire_prefix":"7","prefix_anchor":"7","level":1,"prior_prefix":"6"}},"ancestry":[{"id":13315,"edition_id":1,"name":"Prescription Monitoring Program","identifier":"25.2","label":"chapter","depth":3,"order_by":1,"parent_id":12758,"metadata":{},"date_created":"2026-06-26 03:44:37","date_modified":"2026-06-26 03:44:37","permalink":{"id":241371,"object_type":"structure","relational_id":13315,"identifier":"25.2","token":"54.1\/III\/25.2","url":"\/54.1\/III\/25.2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12758,"edition_id":1,"name":"Professions and Occupations Regulated by Boards Within the Department of Health Professions","identifier":"III","label":"subtitle","depth":2,"order_by":1,"parent_id":12754,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":241105,"object_type":"structure","relational_id":12758,"identifier":"III","token":"54.1\/III","url":"\/54.1\/III\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12754,"edition_id":1,"name":"Professions and Occupations","identifier":"54.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":239313,"object_type":"structure","relational_id":12754,"identifier":"54.1","token":"54.1","url":"\/54.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":68394,"structure_id":13315,"section_number":"54.1-2519","catch_line":"Definitions","url":"\/54.1-2519\/","token":"54.1\/III\/25.2\/54.1-2519","metadata":false},{"id":55075,"structure_id":13315,"section_number":"54.1-2520","catch_line":"Program establishment; Director's regulatory authority","url":"\/54.1-2520\/","token":"54.1\/III\/25.2\/54.1-2520","metadata":false},{"id":64843,"structure_id":13315,"section_number":"54.1-2521","catch_line":"(Effective July 1, 2026) Reporting requirements","url":"\/54.1-2521\/","token":"54.1\/III\/25.2\/54.1-2521","metadata":false},{"id":69685,"structure_id":13315,"section_number":"54.1-2522","catch_line":"(Effective July 1, 2026) Reporting exemptions","url":"\/54.1-2522\/","token":"54.1\/III\/25.2\/54.1-2522","metadata":false},{"id":72705,"structure_id":13315,"section_number":"54.1-2522.1","catch_line":"(Effective July 1, 2027) Requirements of practitioners","url":"\/54.1-2522.1\/","token":"54.1\/III\/25.2\/54.1-2522.1","metadata":false},{"id":67799,"structure_id":13315,"section_number":"54.1-2522.2","catch_line":"Requirements for dispensers","url":"\/54.1-2522.2\/","token":"54.1\/III\/25.2\/54.1-2522.2","metadata":false},{"id":56919,"structure_id":13315,"section_number":"54.1-2523","catch_line":"Confidentiality of data; disclosure of information; discretionary authority of Director","url":"\/54.1-2523\/","token":"54.1\/III\/25.2\/54.1-2523","metadata":false},{"id":74465,"structure_id":13315,"section_number":"54.1-2523.1","catch_line":"Criteria for indicators of misuse; Director's authority to disclose information; intervention","url":"\/54.1-2523.1\/","token":"54.1\/III\/25.2\/54.1-2523.1","metadata":false},{"id":56473,"structure_id":13315,"section_number":"54.1-2523.2","catch_line":"(Effective July 1, 2027) Authority to access database","url":"\/54.1-2523.2\/","token":"54.1\/III\/25.2\/54.1-2523.2","metadata":false},{"id":57186,"structure_id":13315,"section_number":"54.1-2524","catch_line":"Immunity from liability","url":"\/54.1-2524\/","token":"54.1\/III\/25.2\/54.1-2524","metadata":false},{"id":57288,"structure_id":13315,"section_number":"54.1-2525","catch_line":"Unlawful disclosure of information; disciplinary action authorized; penalties","url":"\/54.1-2525\/","token":"54.1\/III\/25.2\/54.1-2525","metadata":false},{"id":54302,"structure_id":13315,"section_number":"54.1-2526","catch_line":"Exemption of information systems from provisions related to the Virginia Information Technologies Agency","url":"\/54.1-2526\/","token":"54.1\/III\/25.2\/54.1-2526","metadata":false}],"previous_section":{"id":64843,"structure_id":13315,"section_number":"54.1-2521","catch_line":"(Effective July 1, 2026) Reporting requirements","url":"\/54.1-2521\/","token":"54.1\/III\/25.2\/54.1-2521","metadata":false},"next_section":{"id":72705,"structure_id":13315,"section_number":"54.1-2522.1","catch_line":"(Effective July 1, 2027) Requirements of practitioners","url":"\/54.1-2522.1\/","token":"54.1\/III\/25.2\/54.1-2522.1","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/54.1-2522\/","history_text":"

This law was first created in 2002. The record of its establishment is cataloged in chapter 481<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 3 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 2018, chapter 772<\/a>; in 2019, chapter 686<\/a>; in 2025, chapter 298<\/a>.<\/p>","references":[{"id":64843,"section_number":"54.1-2521","catch_line":"(Effective July 1, 2026) Reporting requirements","order_by":null,"url":"\/54.1-2521\/"}],"refers_to":[{"id":64843,"section_number":"54.1-2521","catch_line":"(Effective July 1, 2026) Reporting requirements","order_by":null,"url":"\/54.1-2521\/"}],"permalink":{"id":241385,"object_type":"law","relational_id":69685,"identifier":"54.1-2522","token":"54.1\/III\/25.2\/54.1-2522","url":"\/54.1-2522\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/54.1-2522\/","token":"54.1\/III\/25.2\/54.1-2522","dublin_core":{"Title":"(Effective July 1, 2026) Reporting exemptions","Type":"Text","Format":"text\/html","Identifier":"\u00a7 54.1-2522","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

The dispensing of covered substances<\/span> under the following circumstances shall be exempt from the reporting requirements set forth in \u00a7 54.1-2521<\/a>:<\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> Dispensing of manufacturers’ samples of such covered substances<\/span> or of covered substances<\/span> dispensed pursuant to an indigent<\/span> patient program offered by a pharmaceutical manufacturer. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> Dispensing of covered substances<\/span> by a practitioner of the healing arts to his patient in a bona fide medical emergency or when pharmaceutical services are not available. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> Administering of covered substances<\/span>.\n\t\t\tDispensing of covered substances<\/span> to inpatients in hospitals or nursing facilities licensed by the Board of Health or facilities that are otherwise authorized by law<\/span> to operate as hospitals or nursing homes in the Commonwealth. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

5.<\/span> Dispensing of covered substances<\/span> to inpatients in hospices licensed by the Board of Health. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

6.<\/span> Dispensing of covered substances<\/span> by veterinarians to animals within the usual course of their professional practice for a course of treatment to last seven days or less or if such covered substance<\/span> is feline buprenorphine or canine butorphanol. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

7.<\/span> Dispensing of covered substances<\/span> as otherwise provided in the Department<\/span>’s regulations. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\n(EFFECTIVE JULY 1, 2026) REPORTING EXEMPTIONS (\u00a7 54.1-2522)\n\nThe dispensing of covered substances under the following circumstances shall be\nexempt from the reporting requirements set forth in \u00a7 54.1-2521:\n\n1. Dispensing of manufacturers’ samples of such covered substances or of\ncovered substances dispensed pursuant to an indigent patient program offered by\na pharmaceutical manufacturer.\n\n2. Dispensing of covered substances by a practitioner of the healing arts to his\npatient in a bona fide medical emergency or when pharmaceutical services are not\navailable.\n\n3. Administering of covered substances.\n\t\t\tDispensing of covered substances to inpatients in hospitals or nursing\nfacilities licensed by the Board of Health or facilities that are otherwise\nauthorized by law to operate as hospitals or nursing homes in the Commonwealth.\n\n5. Dispensing of covered substances to inpatients in hospices licensed by the\nBoard of Health.\n\n6. Dispensing of covered substances by veterinarians to animals within the usual\ncourse of their professional practice for a course of treatment to last seven\ndays or less or if such covered substance is feline buprenorphine or canine\nbutorphanol.\n\n7. Dispensing of covered substances as otherwise provided in the\nDepartment’s regulations.\n\nHISTORY: 2002, c. 481; 2018, c. 772; 2019, c. 686; 2025, c. 298.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}